Toinv - good analysis and post:

'This suggests to me that ORI is not about to suffer fools for too long.'

'Like Buckeyes I have mixed feelings about Hepalink and ORI. There are many options that could occur. I just hope that one of the options will benefit retail shareholders like me. It can't get much worse than the current situation'

DM once said he consults with Hepa on a daily basis. Hepa already has license for apabetalone in China and territories - they pay 50% of BOMIII - their return is commercialization in China - they also funded BOM @ 2.67 per sh..

ORI should have no problem reaching the Ori Fund exit multiple of 2.88 on their 1.08 per sh investment = 3.11 mv per sh. 

3.11 per sh X 350million (upcoming financing dilution) fully dilluted sh O/S = 1.1billion.  market cap 

Hepa is a China Co - Ori is Hong Kong Goldman Sachs - also China controlled ?

US BP  controls Covid vaccines & therapeutics & WHO

Successful Covid PhII results, if they occur, should be the catalyst for a BP takeover 

Where is Zenith in all this? How about Zenith royalties on apb?

And what happened to the sheik? How about the market valuation prepared for the sheik?

And what happens to RVX shareholders?

Shoulda put my money in bitcoin?

Just my opinions and musings trying to make some sense of this mess

Chicagoest